Change description : 2025-06-06 11:02:00: Document updated to align with the changes to the childhood immunisation schedule from 1 July 2025, moving second MenB dose to 12 weeks from 16 weeks. [Guidance and regulation]
The PDF version of this guidance has been replaced by an HTML version. The title has been changed to clearly distinguish this guidance from that for other programmes. The guidance includes updated epidemiological information, and the references to latex and black triangle labelling have been removed.
1 July 2021
Added revised guidance.
14 January 2019
Updated document.
18 February 2016
Updated to reflect the recent supply constraints for the supply of Bexsero® to the private market.